Cyclerion Therapeutics (CYCN) Cash from Operations (2018 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Cash from Operations of 264000.0 in Q3 2025, up 47.51% quarter-over-quarter from 503000.0 in Q2 2025, and up 84.62% on a YoY basis from 143000.0 in Q3 2024.
Cyclerion Therapeutics (CYCN) Cash from Operations (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Cash from Operations history runs 8 years deep, the most recent figure standing at 264000.0 for Q3 2025.
- In Q3 2025, Cash from Operations rose 84.62% year-over-year to 264000.0; the TTM figure through Sep 2025 stood at 1375000.0 (up 77.94% YoY), while the FY2024 annual figure was 4333000.0, up 79.6% from the prior year.
- Cash from Operations was 264000.0 for Q3 2025 at Cyclerion Therapeutics, up from 503000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 360000.0 in Q4 2024 to a low of 14455000.0 in Q1 2021.
- Historically, Cash from Operations has averaged 5496894.74 across 5 years, with a median of 6214000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations tumbled 96.37% in 2022, then surged 123.36% in 2024.
- A 5-year view of Cash from Operations shows it stood at 8630000.0 in 2021, then gained by 18.39% to 7043000.0 in 2022, then soared by 78.12% to 1541000.0 in 2023, then soared by 123.36% to 360000.0 in 2024, then slumped by 173.33% to 264000.0 in 2025.
- The last three Cash from Operations figures came in at 264000.0 (Q3 2025), 503000.0 (Q2 2025), and 968000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -264,000.00 |
| Sep 30, 2025 | -264,000.00 |
| Jun 30, 2025 | -503,000.00 |
| Jun 30, 2025 | -503,000.00 |
| Mar 31, 2025 | -968,000.00 |
| Mar 31, 2025 | -968,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Sep 30, 2024 | -1.72 Mn |
| Sep 30, 2024 | -1.72 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | -1.54 Mn |
| Dec 31, 2023 | -1.54 Mn |
| Sep 30, 2023 | -6.94 Mn |
| Sep 30, 2023 | -6.94 Mn |
| Jun 30, 2023 | -6.56 Mn |
| Jun 30, 2023 | -6.56 Mn |